Published in J Gen Virol on May 01, 1998
Emergence of zoonotic arboviruses by animal trade and migration. Parasit Vectors (2010) 2.02
Potential arbovirus emergence and implications for the United Kingdom. Emerg Infect Dis (2006) 1.17
Enzootic transmission of yellow fever virus in Peru. Emerg Infect Dis (2003) 1.06
Characterization of a siberian virus isolated from a patient with progressive chronic tick-borne encephalitis. J Virol (2003) 1.02
New insights into flavivirus evolution, taxonomy and biogeographic history, extended by analysis of canonical and alternative coding sequences. PLoS One (2015) 0.98
Evolution of bovine respiratory syncytial virus. J Virol (2000) 0.90
Revisiting the clinal concept of evolution and dispersal for the tick-borne flaviviruses by using phylogenetic and biogeographic analyses. J Virol (2012) 0.86
First dating of a recombination event in mammalian tick-borne flaviviruses. PLoS One (2012) 0.83
Rapid molecular detection methods for arboviruses of livestock of importance to northern Europe. J Biomed Biotechnol (2011) 0.78
Louping ill virus in the UK: a review of the hosts, transmission and ecological consequences of control. Exp Appl Acarol (2015) 0.75
Alexander the Great and West Nile virus encephalitis. Emerg Infect Dis (2004) 0.75
Revisiting Recombination Signal in the Tick-Borne Encephalitis Virus: A Simulation Approach. PLoS One (2016) 0.75
HIV evolution: CTL escape mutation and reversion after transmission. Nat Med (2004) 10.21
Highly pathogenic H5N1 influenza virus infection in migratory birds. Science (2005) 9.64
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol (1993) 8.07
Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc Natl Acad Sci U S A (2001) 7.90
Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med (2001) 6.51
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol (1993) 6.41
The epidemic behavior of the hepatitis C virus. Science (2001) 4.81
Evolutionary aspects of recombination in RNA viruses. J Gen Virol (1999) 3.74
Population dynamics of flaviviruses revealed by molecular phylogenies. Proc Natl Acad Sci U S A (1996) 3.69
Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery (1968) 3.56
Extinction rates can be estimated from molecular phylogenies. Philos Trans R Soc Lond B Biol Sci (1994) 3.47
Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol (1992) 3.37
Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol (1993) 2.87
Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci U S A (2006) 2.77
First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality! Clin Microbiol Infect (2010) 2.53
Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period. Virology (2002) 2.53
Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol (1994) 2.53
Ecology and evolution of rabies virus in Europe. J Gen Virol (1999) 2.52
Causes of HIV diversity. Nature (1995) 2.48
TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity (1999) 2.33
Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect (2004) 2.30
Tick-borne encephalitis. Antiviral Res (2003) 2.25
Inferring population history from molecular phylogenies. Philos Trans R Soc Lond B Biol Sci (1995) 2.21
Human immunodeficiency virus. Phylogeny and the origin of HIV-1. Nature (2001) 2.20
A likelihood method for the detection of selection and recombination using nucleotide sequences. Mol Biol Evol (1997) 2.20
Phylogenetic relationships of flaviviruses correlate with their epidemiology, disease association and biogeography. J Gen Virol (2001) 2.19
Investigation of potential HIV transmission to the patients of an HIV-infected surgeon. JAMA (1993) 2.17
BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg (1974) 2.14
Widespread intra-serotype recombination in natural populations of dengue virus. Proc Natl Acad Sci U S A (1999) 2.12
Networks and groups within the genus Neisseria: analysis of argF, recA, rho, and 16S rRNA sequences from human Neisseria species. Mol Biol Evol (1999) 2.10
The role of MCM proteins in the cell cycle control of genome duplication. Bioessays (1996) 2.09
The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. J Thorac Cardiovasc Surg (1991) 2.06
The relationships between West Nile and Kunjin viruses. Emerg Infect Dis (2001) 2.03
Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.00
T cell receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently and with distinct kinetics. Immunity (1999) 1.98
Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer (1994) 1.95
Parathyroid carcinoma: a collective review. Ann Surg (1969) 1.94
Genealogical evidence for positive selection in the nef gene of HIV-1. Genetics (1999) 1.93
A rational approach to the surgical management of melanoma. Ann Surg (1977) 1.88
Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology (1991) 1.85
Complete coding sequence of the Alkhurma virus, a tick-borne flavivirus causing severe hemorrhagic fever in humans in Saudi Arabia. Biochem Biophys Res Commun (2001) 1.85
Secondary structure of the 3' untranslated region of flaviviruses: similarities and differences. Nucleic Acids Res (1997) 1.84
Monoclonal antibodies to Sindbis virus glycoprotein E1 can neutralize, enhance infectivity, and independently inhibit haemagglutination or haemolysis. J Gen Virol (1982) 1.77
A multigene analysis of the phylogenetic relationships among the flaviviruses (Family: Flaviviridae) and the evolution of vector transmission. Arch Virol (2005) 1.72
An arbovirus cline across the northern hemisphere. Virology (1995) 1.67
Complete sequence of two tick-borne flaviviruses isolated from Siberia and the UK: analysis and significance of the 5' and 3'-UTRs. Virus Res (1997) 1.63
PCR detection of the sheep-associated agent of malignant catarrhal fever. Arch Virol (1993) 1.62
Molecular epidemiology of dengue virus type 3 in Venezuela. J Gen Virol (2003) 1.61
Epidemic dynamics revealed in dengue evolution. Mol Biol Evol (2009) 1.58
The molecular evolution of the alcohol dehydrogenase and alcohol dehydrogenase-related genes in the Drosophila melanogaster species subgroup. Mol Biol Evol (1994) 1.58
Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma. N Engl J Med (1976) 1.57
Phylogenetic relationships among rhabdoviruses inferred using the L polymerase gene. J Gen Virol (2005) 1.55
Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. J Gen Virol (1986) 1.55
Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet (1995) 1.54
Genetic diversity of Borrelia burgdorferi sensu lato in ticks from mainland Portugal. J Clin Microbiol (2000) 1.50
Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties. J Biol Chem (1999) 1.50
Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies. J Gen Virol (1985) 1.50
In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. J Virol (1994) 1.50
Molecular epidemiology of dengue type 2 virus in Venezuela: evidence for in situ virus evolution and recombination. J Gen Virol (2001) 1.48
Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. J Gen Virol (1996) 1.46
A reevaluation of the higher taxonomy of viruses based on RNA polymerases. J Virol (1996) 1.44
Johne's disease in a herd of farmed red deer. Vet Rec (1995) 1.44
Population dynamics of HIV-1 inferred from gene sequences. Genetics (1999) 1.43
A phylogenetic survey of recombination frequency in plant RNA viruses. Arch Virol (2005) 1.39
Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation. Immunol Lett (2001) 1.37
Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group. Oncogene (1995) 1.34
Genetic analysis of Israel acute paralysis virus: distinct clusters are circulating in the United States. J Virol (2008) 1.34
Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. Cancer Causes Control (1991) 1.34
Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning. Proc Natl Acad Sci U S A (2000) 1.33
Variable immune-driven natural selection in the attachment (G) glycoprotein of respiratory syncytial virus (RSV). J Mol Evol (2001) 1.32
Infectious transcripts of tick-borne encephalitis virus, generated in days by RT-PCR. Virology (1995) 1.32
Evidence for the non-quasispecies evolution of RNA viruses [corrected]. Mol Biol Evol (2001) 1.31
Nucleotide sequence of the envelope glycoprotein of Negishi virus shows very close homology to louping ill virus. Virology (1992) 1.29
Single amino acid codon changes detected in louping ill virus antibody-resistant mutants with reduced neurovirulence. J Gen Virol (1993) 1.28
Secondary structure of the 3'-untranslated region of yellow fever virus: implications for virulence, attenuation and vaccine development. J Gen Virol (1997) 1.28
Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system. J Card Surg (2000) 1.28
Infection patterns in mice of an avirulent and virulent strain of Semliki Forest virus. Br J Exp Pathol (1971) 1.26
Immune and artificial selection in the haemagglutinin (H) glycoprotein of measles virus. J Gen Virol (2001) 1.26
Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis. J Hepatol (2001) 1.25
The vulnerability of the hippocampus to protective and destructive effects of glucocorticoids in relation to stress. Br J Psychiatry Suppl (1992) 1.24
Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change. J Gen Virol (1993) 1.24
Analysis of flavivirus envelope proteins reveals variable domains that reflect their antigenicity and may determine their pathogenesis. Virus Res (1995) 1.24
Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst (1993) 1.23
Primer Master: a new program for the design and analysis of PCR primers. Comput Appl Biosci (1996) 1.23
Biological consequences of deletions within the 3'-untranslated region of flaviviruses may be due to rearrangements of RNA secondary structure. Virus Res (1999) 1.22
Derivation of a DNA clone corresponding to the viral agent of sheep-associated malignant catarrhal fever. Res Vet Sci (1991) 1.22
New inferences from tree shape: numbers of missing taxa and population growth rates. Syst Biol (2002) 1.22